TY - JOUR
T1 - COVID-19 vaccination experience among United States dental professionals and students
T2 - Safety, confidence, concerns, and side effects
AU - Bsoul, Enas A.
AU - Loomer, Peter M.
N1 - Publisher Copyright:
© 2022 Bsoul, Loomer. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
PY - 2022/2
Y1 - 2022/2
N2 - Objectives The purpose of this study was to evaluate the COVID-19 vaccination experience among United States-based dental professionals and students: To understand their beliefs, concerns, safety and confidence levels, and side effects experienced after vaccination; striving to boost vaccination acceptability to curtail the pandemic. Methods An observational survey study approved by The University of Texas Health San Antonio Institutional Review Board was distributed to members of the School of Dentistry community using Qualtrics XM software. The survey was completed anonymously. Data were analyzed using R statistical computing software, X2 test and Fisher's Exact test. Results Over 80% of all participants felt moderately to very safe working after the COVID-19 vaccine was made available, and more than 75% were moderately to very confident that the vaccine can protect them during the pandemic. At least 35% were moderately to very concerned about immediate and long-term side effects of the vaccine; despite the concerns, 94% received the vaccine. Side effects were more common after the second dose of the vaccine. Most common side effects were injection site pain, and general side effects of fatigue/tiredness, headache, muscle/body ache, and chills/fever. 74% reported no effect of the vaccine on daily activities, and the severity of side effects no worse than mild (about 60%). Conclusions Majority of the participants felt safe and confident that the vaccine would protect them against COVID-19 infection. Sharing these findings and reliable information that the vaccine is safe and effective is paramount to fostering the vaccine uptake and curtailing the pandemic.
AB - Objectives The purpose of this study was to evaluate the COVID-19 vaccination experience among United States-based dental professionals and students: To understand their beliefs, concerns, safety and confidence levels, and side effects experienced after vaccination; striving to boost vaccination acceptability to curtail the pandemic. Methods An observational survey study approved by The University of Texas Health San Antonio Institutional Review Board was distributed to members of the School of Dentistry community using Qualtrics XM software. The survey was completed anonymously. Data were analyzed using R statistical computing software, X2 test and Fisher's Exact test. Results Over 80% of all participants felt moderately to very safe working after the COVID-19 vaccine was made available, and more than 75% were moderately to very confident that the vaccine can protect them during the pandemic. At least 35% were moderately to very concerned about immediate and long-term side effects of the vaccine; despite the concerns, 94% received the vaccine. Side effects were more common after the second dose of the vaccine. Most common side effects were injection site pain, and general side effects of fatigue/tiredness, headache, muscle/body ache, and chills/fever. 74% reported no effect of the vaccine on daily activities, and the severity of side effects no worse than mild (about 60%). Conclusions Majority of the participants felt safe and confident that the vaccine would protect them against COVID-19 infection. Sharing these findings and reliable information that the vaccine is safe and effective is paramount to fostering the vaccine uptake and curtailing the pandemic.
UR - http://www.scopus.com/inward/record.url?scp=85125155293&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85125155293&partnerID=8YFLogxK
U2 - 10.1371/journal.pone.0264323
DO - 10.1371/journal.pone.0264323
M3 - Article
C2 - 35192657
AN - SCOPUS:85125155293
SN - 1932-6203
VL - 17
JO - PloS one
JF - PloS one
IS - 2 February
M1 - e0264323
ER -